1. Background
2. Objectives
3. Patients and Methods
3.1. Analysis of Acinetobacter baumannii Species Isolated From Clinical Samples
| Clinical Samples | ICU | Respiration Medicine | Burn and Plastic Surgery | Total in the Same Samples |
|---|---|---|---|---|
| Blood culture | 33 | 31 | 27 | 91 |
| Sputum culture | 15 | 18 | - | 33 |
| Wound swab | - | - | 16 | 16 |
| Total in the same department | 48 | 49 | 43 | 140 |
3.2. Multilocus Sequence Typing
| House-Keeping Genes Primer | Sequences (5’-3’) |
|---|---|
| gltA | |
| F | AATTTACAGTGGCACATTAGGTCCC |
| R | GCAGAGATACCAGCAGACATACACG |
| gyrB | |
| F | GAATGCTGGTGTACGTATCG |
| R | ACGCTCAACGTTCAGGATCT |
| gdhB | |
| F | GTTAACCGAACGTGCAACTG |
| R | GCATAGGCATAACCACTGTC |
| RecA | |
| F | CCTGAATCTTCCGGTAAAAC |
| R | GTTTCTGGGCTGCCAAACATTAC |
| cpn60 | |
| F | ACTAACGACATCGCAGGTGA |
| R | CGCGATGTCTTGAAGCATTG |
| gpi | |
| F | AATACCGTGGTGCTACGGG |
| R | ATCGAAATTACCAAACGAAGGTT |
| rpoD | |
| F | ATCGAAATTACCAAACGAAGGTT |
| R | ACGACAGACCCTGTACGTATGTA |
a Abbreviations: F, forward primer; and R, reverse primer.
3.3. Analysis of Drug Resistance and Related Genes
| Target Genes Primer | Sequence (5’-3’) |
|---|---|
| oxa-23 | |
| F | GATGTGTCATAGTATTCGTCGT |
| R | TCACAACAACTAAAAGCACTGT |
| oxa-24 | |
| F | ATGAAAAAATTTATACTTCCTATATTCAGC |
| R | TTAAATGATTCCAAGATTTTCTAGC |
| oxa-51 | |
| F | TAATGCTTTGATCGGCCTTG |
| R | TGGATTGCACTTCATCTTGG |
| sim | |
| F | TACAAGGGATTCGGCATCG |
| R | TAATGGCCTGTTCCCATGTG |
| imp-1 | |
| F | ATCCAAGCAGCAAGCGCGTTA |
| R | AGGCGTGCTGCTGCAACGACTTGT |
| spm | |
| F | ATTGGTCTATTTGACCGCGTC |
| R | TGCTACTCAACGACTGAGCG |
| intl1 | |
| F | CAGTGGACATAAGCCTGTTC |
| R | CCCGAGGCATAGACTGTA |
| qacEΔ1-sul1 | |
| F | TAGCGAGGGCTTTACCTAAGC |
| R | ATTCAGAATGCCGAACACCG |
a Abbreviations: F, forward primer; R, reverse primer
3.4. Statistical Analysis
4. Results
4.1. Detection of the Drug-Resistance Ability of the Isolates
| Antibiotics | MICrange | MIC50 | MIC90 | Resistance Rate, % |
|---|---|---|---|---|
| IMP | 0.5 - 512 | 32 | 512 | 43.1 |
| ATM | 0.25 - 256 | 16 | 256 | 31.8 |
| FEP | 0.03 - 512 | 16 | 512 | 62.3 |
| CFP | 0.03 - 512 | > 512 | > 512 | 100.0 |
| PIP | 0.5 - 512 | 512 | > 512 | 89.4 |
| AMK | 0.5 - 512 | > 512 | > 512 | 100.0 |
| CIP | 0.03 - 512 | > 512 | > 512 | 100.0 |
| CTX | 0.03 - 512 | 256 | > 512 | 67.4 |
a Abbreviations: AMK, amikacin; ATM, aztreonam; CFP, cefoperazone; CIP, ciprofloxacin; CTX, cefotaxime; FEP, cefepime; MIC, minimum inhibitory concentration; PIP, piperacillin; MIC50, minimum inhibitory concentration required to inhibit the growth of 50% of organisms; and MIC90, minimum inhibitory concentration required to inhibit the growth of 90% of organisms.
| Groups c | Clinical Departments | Clinical Specimens | ||||
|---|---|---|---|---|---|---|
| ICU | Res | Bur and Pla | Blood | Sputum | Wound | |
| I | 39 (81.25) | 26 (53.06) | 18 (41.86) | 58 (63.74) | 19 (57.58) | 6 (37.50) |
| II | 8 (16.67) | 21 (42.86) | 22 (51.16) | 29 (31.87) | 14 (42.42) | 8 (50.00) |
| III | 1 (2.08) | 2 (4.08) | 3 (6.98) | 4 (4.40) | 0 (0.00) | 2 (12.50) |
| Total | 48 (100) | 49 (100) | 43 (100) | 91 (100) | 33 (100) | 16 (100) |
a Abbreviations: Bur and Pla; department of burn and plastic surgery; ICU, intensive care unit; and Res, department of respiratory medicine.
b Number refers to the number of the isolates from a certain department or samples. Percentage refers to the rate in total number; for example, 39 (81.25) means 39 cases out of 48, 39/48 = 81.25%.
c Groups; the groups I, II, III refer to the group classified by the study group.
4.2. Results of Multilocus Sequence Typing
a Abbreviations: Bur and Pla, Department of Burn and Plastic Surgery, ICU, department of intensive care unit; and Res, department of respiration medicine.
b Number refers to the number of the species isolated from a certain department or sample. Percentage refers to the rate in total number; for example, 40 (83.3) means 40 cases out of 48, 40/48 = 83.3%.
c Number in this group has a significant difference compared with those in other groups (P value < 0.05).
4.3. Detection of Drug-Resistance Genes Expression
a Abbreviations: CRAB, carbapenem-resistant AB; and CSAB, carbapenem-susceptible AB.
b There are significant differences in this group CRAB compared with those in CSAB, P value < 0.05.
a Data are presented as number of the isolates (which express the gene) per number of the stains.
b There are significant differences in ST208 compared with ST218, P < 0.05.